These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33099406)

  • 21. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.
    Zhu ZC; Liu JW; Yang C; Li MJ; Wu RJ; Xiong ZQ
    Cell Death Dis; 2019 Feb; 10(2):118. PubMed ID: 30742128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
    Bui HTT; Le NH; Le QA; Kim SE; Lee S; Kang D
    Int J Med Sci; 2019; 16(11):1412-1423. PubMed ID: 31673231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
    Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
    Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP.
    Piggott L; Silva A; Robinson T; Santiago-Gómez A; Simões BM; Becker M; Fichtner I; Andera L; Young P; Morris C; Barrett-Lee P; Alchami F; Piva M; Vivanco MD; Clarke RB; Gee J; Clarkson R
    Clin Cancer Res; 2018 May; 24(10):2452-2463. PubMed ID: 29363524
    [No Abstract]   [Full Text] [Related]  

  • 28. ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.
    Yang J; Yang C; Zhang S; Mei Z; Shi M; Sun S; Shi L; Wang Z; Wang Y; Li Z; Xie C
    Cancer Biol Ther; 2015; 16(8):1194-204. PubMed ID: 26054751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming resistance to trail-induced apoptosis in prostate cancer by regulation of c-FLIP.
    Zhang X; Li W; Olumi AF
    Methods Enzymol; 2008; 446():333-49. PubMed ID: 18603132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Perspectives of Single-Cell RNA Sequencing.
    Kim N; Eum HH; Lee HO
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 71-gene signature of TRAIL sensitivity in cancer cells.
    Chen JJ; Knudsen S; Mazin W; Dahlgaard J; Zhang B
    Mol Cancer Ther; 2012 Jan; 11(1):34-44. PubMed ID: 22027696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer.
    Arafat W; Zhou T; Naoum GE; Buchsbaum DJ
    J Egypt Natl Canc Inst; 2015 Dec; 27(4):205-15. PubMed ID: 26385392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation.
    Hwang SY; Nguyen NH; Kim TJ; Lee Y; Kang MA; Lee JS
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells.
    Aydin C; Sanlioglu AD; Karacay B; Ozbilim G; Dertsiz L; Ozbudak O; Akdis CA; Sanlioglu S
    Hum Gene Ther; 2007 Jan; 18(1):39-50. PubMed ID: 17187448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis.
    Chakravarthy R; Clemens MJ; Pirianov G; Perdios N; Mudan S; Cartwright JE; Elia A
    Biol Cell; 2013 Sep; 105(9):414-29. PubMed ID: 23734772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
    Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
    Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models.
    Kopczynski M; Statkiewicz M; Cybulska M; Kuklinska U; Unrug-Bielawska K; Sandowska-Markiewicz Z; Grochowska A; Gajewska M; Kulecka M; Ostrowski J; Mikula M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.
    Jiang P; Lee W; Li X; Johnson C; Liu JS; Brown M; Aster JC; Liu XS
    Cell Syst; 2018 Mar; 6(3):343-354.e5. PubMed ID: 29428415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer.
    O'Brien C; Cavet G; Pandita A; Hu X; Haydu L; Mohan S; Toy K; Rivers CS; Modrusan Z; Amler LC; Lackner MR
    Cancer Res; 2008 Jul; 68(13):5380-9. PubMed ID: 18593940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative--Enhancement of both extrinsic and intrinsic apoptosis pathways.
    Berger A; Quast SA; Plötz M; Hein M; Kunz M; Langer P; Eberle J
    Biochem Pharmacol; 2011 Jan; 81(1):71-81. PubMed ID: 20858462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.